Clinisys is a global leader in informatics software, supporting diagnostic testing across healthcare, life sciences, and public health. With a presence in over 34 countries and serving more than 3,000 laboratories, Clinisys plays a pivotal role in generating millions of diagnostic results and data insights each day. The company, established in 1988, is headquartered in Tucson, Arizona, and Woking, England.
Operating across nine diverse industries, including healthcare, contract services, crop sciences, environment, water, food and beverage, pharma, life sciences, and public health, Clinisys offers flexible and top-tier solutions to streamline workflows and enhance health outcomes. Its commitment extends to supporting various types of laboratories or remote testing environments, whether in the public or private sector, in-house, or outsourced.
Clinisys positions itself at the forefront of technological advancements, recognizing the crucial role of technology in shaping future preventative healthcare approaches. The company’s mission is to foster digital transformation within the field of diagnostics, contributing to healthier and safer communities worldwide.
As of now, there is no publicly available information about the last investment received or the investors involved with Clinisys.
There is no investment information
No recent news or press coverage available for Clinisys.